Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ambrx Biopharma Inc ADR (NY: AMAM )

10.13 UNCHANGED
Last Price Updated: 7:00 PM EDT, Mar 16, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 10.13
Bid (Size) 10.66 (3)
Ask (Size) 11.24 (1)
Prev. Close 10.13
Today's Range 10.13 - 10.13
52wk Range 0.3800 - 13.07
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023
 
Via Benzinga
Ambrx Biopharma's Oncology Pipeline Is Underappreciated, Analyst Initiating Coverage Says
Cantor Fitzgerald initiated coverage on Ambrx Biopharma Inc (NASDAQ: AMAM) with an Overweight rating and a  
Via Benzinga

Performance

YTD
+389.37%
+389.37%
1 Month
N/A
N/A
3 Month
+1.81%
+1.81%
6 Month
+2054.40%
+2054.40%
1 Year
+152.93%
+152.93%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 19, 2023
Via Benzinga
What 4 Analyst Ratings Have To Say About Ambrx Biopharma
Via Benzinga
Why Shares of Ambrx Biopharma Jumped This Week
Via The Motley Fool
Why Sunrise New Energy Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
Via Benzinga
$59M Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Ambrx Biopharma Highlights Preclinical Data From Studies in Kidney, Prostate Cancer
Via Benzinga
Over $25M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
7 Cheap Stocks That Are Worth Your Attention
Via InvestorPlace
7 Risky Stocks That Are Worth the Stretch
Via InvestorPlace
Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions
Via Benzinga
Ambrx Raises $78 Million and Completes its ATM Program
From Ambrx, Inc.
Via Business Wire
Week In Review: Sino Biopharma Acquires F-Star For $161 Million After US Approval
Via Talk Markets
Why Shares of Ambrx Biopharma Fell Tuesday
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Sheds Over 300 Points After Powell Comments
Via Talk Markets
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nutanix, Cara Therapeutics, Tremor International And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Tesla, Amazon, Ambrx, BridgeBio, Azul: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.